Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis

Background & Aims: Progressive fibrosis has been identified as the major predictor of mortality in patients with non-alcoholic fatty liver disease (NAFLD). Several biomarkers are currently being evaluated for their ability to substitute the liver biopsy as the reference standard. Recent clin...

Full description

Bibliographic Details
Main Authors: Elisabeth Erhardtsen, Daniel G.K. Rasmussen, Peder Frederiksen, Diana Julie Leeming, Diane Shevell, Lise Lotte Gluud, Morten Asser Karsdal, Guruprasad P. Aithal, Jörn M. Schattenberg
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:JHEP Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555921000938